Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QL Block for Analgesia in Abdominoplasty
NCT02949778Phase 4Completed
- Sponsor
- Vestre Viken Hospital Trust
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial in postoperative pain comparing Ropivacaine Group with Placebo Group (2 arms). Primary endpoint: Opioid consumption at 24 hours. Started Nov 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02949778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02949778.